Tag: Drug delivery system

Current estimates show that oral formulations make up about 90% of the global market share for all pharmaceutical products intended for human use [1.5.1]. So, what is the most common drug delivery system? It is unquestionably the oral route, favored for its convenience and patient preference [1.5.1, 1.3.2].

Did you know that matrix tablets were one of the earliest oral technologies used for extended-release drug delivery, with its foundational concepts established in the late 1950s? A matrix tablet is a sophisticated oral dosage form in which an active drug is uniformly dispersed within a rate-controlling polymer system to ensure its gradual release into the body over a predetermined period.

Millions of people worldwide live with glaucoma, a leading cause of irreversible vision loss, and for many, daily eye drops present a challenge to treatment adherence. Durysta was developed as a long-term solution to this issue, but its classification is often misunderstood: Is Durysta a medical device or something else?. It is in fact regulated as a drug delivery system, not a traditional medical device.

While pop culture features a “red pill” from *The Matrix* movie, in pharmacology, a **matrix pill** refers to a tablet designed for extended, controlled drug release. This advanced pharmaceutical formulation embeds medication within a polymer framework, allowing for consistent therapeutic drug levels over a prolonged period and improving patient compliance by reducing dosing frequency.

Over the last decade, organogels have gained significant attention in pharmaceutical science due to their unique properties as a drug delivery vehicle, offering improved stability and controlled release over traditional gel formulations. As such, knowing how to use organogel properly is essential for maximizing its therapeutic benefits across various medical applications, from topical treatments to injectable depots.